JF
INO icon

Jump Financial’s Inovio Pharmaceuticals INO Stock Holding History

Jump Financial’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,756
Closed -$176K – 1865
2024
Q2 		$176K Buy
21,756
+9,879
+83% +$104K ﹤0.01% 1577
2024
Q1 		$165K Buy
+11,877
New +$103K ﹤0.01% 1732
2022
Q4 		– Sell
-1,264
Closed -$26K – 1798
2022
Q3 		$26K Buy
1,264
+364
+40% +$9.32K ﹤0.01% 1519
2022
Q2 		$19K Sell
900
-16,590
-95% -$468K ﹤0.01% 1541
2022
Q1 		$754K Buy
+17,490
New +$788K 0.03% 633
2021
Q4 		– Sell
-6,591
Closed -$566K – 1541
2021
Q3 		$566K Buy
+6,591
New +$661K 0.04% 441
2021
Q2 		– Sell
-4,164
Closed -$463K – 1237
2021
Q1 		$463K Buy
+4,164
New +$548K 0.04% 430

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's INO Position: Q3 2024 in Review

Jump Financial sold out of Inovio Pharmaceuticals (INO) in Q3 2024, closing a stake of 21,756 shares — an estimated $176K sold.

Jump Financial first reported a position in INO in Q1 2021 and held it in 7 quarters. The position peaked at $754K in Q1 2022. 98 funds tracked by Wall St. Rank hold INO as of Q3 2024.

  • Jump Financial reported no remaining Inovio Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 21,756 Inovio Pharmaceuticals shares in Q3 2024, an estimated $176K.
  • Jump Financial first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • Jump Financial's Inovio Pharmaceuticals position peaked at $754K in Q1 2022.
  • 98 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.